Both in Pharmaceuticals
Marker Therapeutics vs Citius Pharmaceuticals
Over the past year MRKR returned −6.1% and CTXR returned −63.0%; their daily moves had a correlation of 0.13.
MRKR −6.1% CTXR −63.0%Growth of $1, one year, split-adjusted
| Metric | MRKR | CTXR |
|---|---|---|
| Price | $0.9011 | $0.5620 |
| Market cap | $15.0M | $15.4M |
| Today | −8.05% | +7.44% |
| 1 month | −14.2% | +5.7% |
| 6 months | −42.2% | −20.9% |
| Year to date | −39.5% | −27.7% |
| 1 year | −8.7% | −64.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 67.1% |
| Net margin | — | −593.3% |
| P/E (TTM) | — | — |
| Price / sales | 6.4× | 2.2× |
| Net cash | $11.3M | $10.6M |
| Dividend yield | — | — |
| Volatility (60d) | 83.9% | 96.5% |
| Short % of float | 0.8% | 21.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).